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Available online 24 February 2016Osteoporosis is often underdiagnosed and undertreated. Screening of post-menopausal women for clinical risk fac-
tors and/or low bone mineral density (BMD) has been proposed to overcome this. Digital X-ray radiogrammetry
(DXR) estimates handBMD fromstandard handX-ray images andhave shown to predict fractures and osteoporosis.
Recently, digital radiology and the internet have opened up the possibility of conducting automated opportunistic
screening with DXR in post-fracture care or in combination with mammography. This study compared the perfor-
mance of DXR with FRAX® and DXA in discriminating major osteoporotic fracture (MOF) (hip, clinical spine, fore-
arm or shoulder), hip fracture and femoral neck osteoporosis. This prospective cohort studywas conducted on 5278
women 65 years and older in the Study of Osteoporotic Fractures (SOF) cohort. Baseline hand X-ray images were
analyzed and fractures were ascertained during 10 years of follow up. Age-adjusted area under receiver operating
characteristic curve (AUC) for MOF and hip fracture and for femoral neck osteoporosis (DXA FN BMD T-score
≤−2.5)was used to compare themethods. Sensitivity to femoral neck osteoporosis at equal selection rateswas tab-
ulated for FRAX and DXR. DXR-BMD, FRAX (no BMD) and lumbar spine DXA BMD were all similar in fracture dis-
criminative performance with an AUC around 0.65 for MOF and 0.70 for hip fractures for all three methods. As
expected femoral neck DXA provided fracture discrimination superior both to other BMD measurements and to
FRAX. AUC for selection of patients with femoral neck osteoporosis was higher with DXR-BMD, 0.76 (0.74–0.77),
thanwith FRAX, 0.69 (0.67–0.71), (p b 0.0001). In conclusion, DXR-BMDdiscriminates incident fractures to a similar
degree as FRAX andpredicts femoral neck osteoporosis to a larger degree than FRAX. DXR shows promise as ameth-
od to automatically ﬂag individuals who might beneﬁt from an osteoporosis assessment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Fragility fractures represent a major public health and economic
burden in the European Union and United States [1,2]. There are cost-
effective pharmacologic interventions available [1,3,4], but the cost–
risk–beneﬁt proﬁle heavily favors treating only those who have the
highest risk for fractures.
The gold standard for selecting those who would beneﬁt from anti-
osteoporotic intervention is bonemineral density (BMD) measurement
by dual energy X-ray absorptiometry (DXA) of the femoral neck and/oreral density; DXA, dual energy
etry; FN, femoral neck; MOF,
OF, the Study of Osteoporotic
nization.
ing, Sweden.
ten).
. This is an open access article undertotal hip and lumbar spine [5,6]. However, due to cost, workﬂow and ac-
cessibility not all eligible women are evaluated with central DXA [1,7].
More accessible and lower cost techniques for identifying individuals
who would beneﬁt from anti-osteoporotic intervention or further eval-
uation by central DXA, if available, might improve patient care [1,8].
Besides central DXA an increased risk for fracture can be identiﬁed
based on measurements at a variety of peripheral bone sites including
heel, radius, metacarpals and phalanges; by a variety of technologies in-
cluding DXA, quantitative ultrasound, radiographic absorptiometry and
radiogrammetry. Performance varies between measurement sites and
technology, but the primary disadvantage of all peripheral measure-
ments is a weaker ability to discriminate hip fractures than DXA BMD
measured in the femoral neck.
Besides BMD, there exist form-based tools with clinical risk factors
for fracture. One such tool, embraced by theWorld Health Organization
(WHO) and frequently cited in national guidelines, is the FRAX® online
tool [9]. Since patient clinical risk factors can be collected and the formthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Digital X-ray radiogrammetry measurement regions on a hand X-ray image.
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sible and is low cost.
Digital X-ray radiogrammetry (DXR) is a software technique to esti-
mate bone mineral density in the hand (DXR-BMD). DXR estimates
BMD through an automated radiogrammetric analysis; cortical thick-
ness, width and porosity, of the three middle metacarpal bones in a
standard hand radiograph [10]. DXR was ﬁrst introduced in the late
nineties in a hardware device and later as a software workstation but
like all peripheral BMD systems of the time it eventually failed and
never reached widespread use. Today however, the advents of digital
radiology systems, electronic medical records and the internet have
fundamentally changed the conditions and enable a large degree of au-
tomation and efﬁciency. DXR can be performed on hand images ac-
quired with any digital X-ray machine including those used for digital
mammography. This means that DXR can be opportunistically integrat-
ed in existing mammography screening workﬂows with small impact
on the workﬂow [11], or used to automatically process all forearm frac-
ture images [12].
Previous studies have shown DXR-BMD measurements to predict
hip, spine and other fractures to a similar degree as other peripheral
BMD measurements [12–15]. Furthermore, DXR-BMD did also predict
osteoporosis as measured by central DXA [15–17]. In healthcare
workﬂows where a patient already is at an X-raymachine, e.g. at mam-
mography screening, suspected fracture or rheumatoid arthritis evalua-
tion, DXR could be an alternative or a complement to FRAX in
identifying individuals at increased risk for fracture requiring evaluation
for possible intervention. To our knowledge there are currently no pub-
lished studies that include both FRAX and DXR.
The purpose of this study was to evaluate and compare the perfor-
mance of DXR, FRAX andDXA in discriminatingmajor osteoporotic frac-
ture (MOF) (hip, clinical spine, forearm or shoulder), hip fracture and
femoral neck osteoporosis.
2. Material and methods
2.1. Subjects and clinical assessments
From 1986 to 1988, 9704 Caucasian women 65 years or older were
recruited for participation in the prospective Study of Osteoporotic Frac-
tures (SOF). Womenwere recruited from population-based listings in 4
regions of the United States [18]. Details of this cohort have been pub-
lished previously [18].
Brieﬂy, at the baseline visit, radiographs of the non-dominant distal
forearm and hand, thoracic spine and lumbar spine were acquired. Sur-
viving participants were invited to a second examination between 1989
and 1990 that includedmeasurement of femoral neck and lumbar spine
BMD by DXA. In total, 7963 women had technically adequate femoral
neck BMDmeasurements. Of these, 6252 had provided data for all clin-
ical risk factors in FRAX. Finally, of these, 5278women had a technically
adequate baseline hand radiograph for DXR-BMD measurement avail-
able and are the subject of this analysis.
The institutional reviewboard at each center approved the study pro-
tocol, and written informed consent was obtained from all participants.
2.2. Clinical risk factors
Participants completed a questionnaire andwere interviewed at the
baseline examination about ethnicity, history of fracture since age of 50,
parental history of hip fracture, physician diagnosis of rheumatoid ar-
thritis, use of oral glucocorticoids, smoking status and alcohol intake.
Measurements of body height and weight were acquired.
2.3. Conﬁrmation of fractures
After baseline, participants were contacted every 4months, by post-
card or telephone, to enquire about recent fractures. More than 98% ofthese follow-up contacts were completed. Reported fractureswere con-
ﬁrmed by review of radiology reports. Ten years was selected as censor-
ing horizon to match that of the FRAX tool.
2.4. Central bone mineral density
The BMD of the lumbar spine and the proximal femur including the
femoral neck (FN) subregion were measured by means of DXA (QDR
1000, Hologic, Waltham, Massachusetts). Details regarding the mea-
surement and quality control methods have been published previously
[18].
2.5. Digital X-ray radiogrammetry
Automated DXR (OneScreen, Sectra Osteoporosis Package, Sectra
AB, Linköping, Sweden) was used to calculate BMD (DXR-BMD, g/cm²)
in the metacarpals. The technique has been described in more detail
previously [10,13,19] and will be only brieﬂy summarized here.
DXR is an automated digital version of the traditional technique
of radiogrammetry [20]. A plain digital hand radiograph is sent to a
computer. The system automatically locates measurement regions
around the diaphyses of metacarpals two, three and four respectively,
Fig. 1. It determined the average cortical thickness (Ti) and bone width
(Wi) individually for each metacarpal i, and the bone volume per
projected area (VPAi) was computed assuming a cylindrically shaped
bone:
VPAi ¼ π Ti  1 Ti=Wið Þ
The system computed the combined VPA of the three middle meta-
carpals as a weighted average:
VPAcomb ¼ VPA2 þ VPA3 þ 0:5 VPA4ð Þ=2:5
Table 1
Number of women who suffered a fracture during 10 years of follow-up
Age at baseline Hip fracture (N = 323, 6.1%)a Major osteoporotic fractureb
(N = 873, 17.1%)a
65-69 (N = 2343) 68 (2.9%) 293 (12.9%)
70-74 (N = 1674) 104 (6.2%) 277 (17.2%)
75-79 (N = 847) 87 (10.3%) 190 (23.5%)
80+ (N = 414) 64 (15.5%) 113 (28.5%)
a After excluding 19 unconﬁrmed hip fractures, 184 unconﬁrmed major osteoporotic
fractures.
b Clinical spine, hip, forearm or shoulder fracture.
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the fraction of the cortical bone that is not occupied by bone [21], and
ﬁnally output DXR-BMD as
DXR  BMD ¼ VPAcomb  1 Pð Þ  c
where c is an empirical density constant to calibrate the DXR-BMD so
that the absolute DXR-BMD value best corresponds to the mid-distal
forearm region BMD, as assessed by DXA [22]. DXR-BMD has previously
been found to have a coefﬁcient of variation of 0.28% [23].
The effective radiation dose of a DXR examination is that of the hand
X-ray, in the order of b0.001 mSv [24]. This level of radiation is similar
or lower than a DXA examination and is generally considered negligible.
All DXR-BMD analyses were performed automated and without
knowledge of DXA BMD or other patient data.
2.6. FRAX® tool
This analysis used the FRAX tool [9] (Version 3.0, US Caucasian). The
FRAX tool included the following: age, sex, weight, height, fracture his-
tory, parental history of hip fracture, smoking status, use of oral gluco-
corticoid, presence of rheumatoid arthritis, presence of disorders
strongly associated with osteoporosis (type I diabetes mellitus, osteo-
genesis imperfecta in adults, untreated long-standing hyperthyroidism,
prematuremenopause (b45 years), chronicmalnutrition ormalabsorp-
tion and chronic liver disease), alcohol intake. The FRAX algorithm pro-
vided four fracture probabilities for each subject: The 10-year
probability of MOF and the 10-year probability of hip fracture, each cal-
culated with or without femoral neck BMD data.
2.7. Statistical analysis
Only women with data on clinical risk factors for the calculation of
FRAX 10-year probabilities, total hip BMD and DXR-BMDwere included
in the analysis. Receiver operating characteristic curve analysis was
used to compare methods for discriminating fracture risk and for
predicting femoral neck osteoporosis. A ranked risk method was used
to tabulate observed performance of discrimination methods at equal
selection rate. The tables provide data for performance comparison,
threshold selection and input data for cost effect estimations for
prescreening selection to central DXA by FRAX or by DXR-BMD.
All statistical analyses were performed using SAS version 9.4 (SAS
Institute, Cary, NC, USA). The original analysis plan is available in full
on the SOF Online website [25], analysis plan #812. All source data is
available for download through the SOF website [25].
3. Results
A total of 5278 women were included in the analysis. Average (SD)
age was 71 (5) years and 1797 (34%) had a history of fracture since
age of 50. The average (SD) femoral neck BMD, lumbar spine BMD,
and DXR-BMD were 0.647 (0.111), 0.854 (0.169), and 0.485 (0.059)
g/cm², respectively. The mean (SD) time between baseline (FRAX and
DXR) and the central DXA measurement was 2.1 (0.2) years. Measure-
ment of DXR-BMD was successful in 99.73% of available hand images
and failed in 0.27% of cases (primarily due tomissing anatomy e.g. pros-
thesis in measurement region). In 0.02% of cases the automated DXR
system failed to invalidate an invalid measurement. Compared with
the 4426 women in the SOF cohort excluded from this analysis due
to missing data needed for calculation of FRAX model probabilities
(primarily parental history of hip fracture), central DXA or DXR-BMD,
the 5278 women included in the analytical cohort were, on average,
slightly younger (mean age 71.3 vs. 72.1 years, p b 0.001) and less likely
to report poor to fair health status (15.3% vs. 18.7%, p b 0.001) or prior
history of fracture (34.1% vs. 40.8%, p b 0.001). However, mean bodymass index (26.6 vs. 26.4, p = 0.06) and femoral neck BMD (0.647 vs.
0.652, p = 0.07) were similar between the two groups.
During ten years of follow up, 873 women (17.1%) suffered a major
osteoporotic fracture and of these 323women (6.1%) suffered a hip frac-
ture, Table 1. As expected, the percentage of women who had fractures
increased with older age.
The DXA FN BMD AUC statistic for MOF and hip fracture was 0.68
and 0.75 respectively, Table 2. Corresponding AUC statistics for DXA
lumbar spine BMD, DXR-BMD and FRAX (no BMD, FRAX MOF and
FRAX hip respectively) were similar to each other at 0.65, 0.69; 0.65,
0.69 and 0.64, 0.70 respectively. DXR-BMD + prior fracture and DXR-
BMD + FRAX had near identical AUC for fractures at 0.67 for MOF and
0.71 for hip fracture.
Age-adjusted AUC for selection of patients with femoral neck osteo-
porosis (DXA FN BMD T-score ≤−2.5, ≤0.558 g/cm²) was higher for
DXR-BMD, 0.76 (0.74–0.77); than for FRAX MOF, 0.69 (0.67–0.71) or
age alone, 0.64 (0.61–0.65), (pb0.0001 for both), Table 2. AUC for
FRAX hip was similar as FRAX MOF (data not shown).
The 10-year major osteoporotic fracture rate, 10-year hip fracture
rate, sensitivity to femoral neck osteoporosis (FRAX and DXR-BMD)
and corresponding thresholds have been tabulated in Table 3. The
whole population in 5-year groups has been ranked in deciles according
to each of DXA FN BMD, FRAX (hip, no BMD), FRAX (MOF, no BMD) and
DXR-BMD. The threshold columns list the level at which the cumulative
percentage of thepopulation in the age groupwas reachedwith each re-
spective selection method. The columns under incident fractures show
for each of the methods how many percent of the patients with a mea-
surement below the corresponding threshold suffered an incident frac-
ture within 10 years from baseline. The sensitivity to DXA FN columns
list the observed sensitivity achieved with the corresponding threshold.
A corresponding table, Supplement Table 4, with only the subset of the
population that had a previous fracture is provided in the online
supplement.
4. Discussion
This prospective study is the ﬁrst to directly compare the perfor-
mance of clinical risk factors (FRAX) and automated DXR in identifying
patients with osteoporosis and those at increased risk for fracture. In
this population-based cohort of older community-dwelling women,
fracture prediction was similar between the two methods, while the
DXR method had substantially higher sensitivity than FRAX to discern
those with femoral neck osteoporosis.
Our results are in general agreement with previous published stud-
ies that femoral neck DXA BMD is a stronger predictor of hip fractures
than clinical risk factors alone [26–28] or other BMD sites including
DXR-BMD [13–15,29], whereas non-hip major osteoporotic fractures
are predicted to a similar degree by other BMD sites including lumbar
spine DXA BMD and DXR-BMD. Our results are also in agreement
with expectations based on previous studies individually using FRAX
[26,30] or DXR-BMD [16,17] to select high risk individuals for conﬁrma-
tion with hip DXA.
Combining clinical risk factors and DXR-BMD increased discrimina-
tory performance relative to fractures compared to using either method
Table 2
Discrimination of major osteoporotic fracture (MOF), hip fracture and femoral neck osteoporosis (DXA FN BMD T-score ≤−2.5). Area under the curve (AUC) determined from receiver
operating characteristic (ROC) analysis. Mean and 95 % conﬁdence interval.
AUC MOFa 10 years AUC hip fracture 10 years AUC femoral neck osteoporosis
Age alone 0.59 (0.57, 0.61) 0.68 (0.65, 0.71) 0.64 (0.61, 0.65)
Age + DXR-BMD 0.65 (0.63, 0.67) 0.69 (0.66, 0.72) 0.76 (0.74, 0.77)
Age + DXA FN BMD 0.68 (0.66, 0.70) 0.75 (0.72, 0.77) –
Age + FRAX (no BMD) 0.64 (0.61, 0.65) 0.70 (0.67, 0.73) 0.69 (0.67, 0.71)
Age + DXA L2-L4 BMD 0.65 (0.63, 0.67) 0.69 (0.65, 0.71) –
Age + DXR-BMD + FRAX 0.67 (0.65, 0.69) 0.71 (0.68, 0.74) –
Age + DXR-BMD + prior fracture 0.67 (0.65, 0.69) 0.71 (0.67, 0.73) –
Age + DXA FN BMD + FRAX 0.69 (0.67, 0.70) 0.76 (0.73, 0.78) –
BMD: bone mineral density; DXA FN: femoral neck BMD by DXA; DXR: metacarpal BMD estimated by digital X-ray radiogrammetry
a Clinical spine, hip, forearm or shoulder fracture.
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to that of DXR-BMD + prior fracture, which indicates that in a post-
fracture workﬂow, adding the complexity of collecting additional
clinical risk factors might add only marginally to discrimination
performance.
Although area under receiver operating characteristic curves is a
widely used method for relative comparison of different screening
methods, they are not straightforward to use for threshold selection or
as input for cost-effect comparisons in a two-step screening process.
Table 3 and Supplement Table 4 are provided to serve as inputwhen es-
timating screening performance at equal selection rates with different
selection methods, to serve as input for threshold selection and as to
serve as input for various cost-effect calculations. For example, a selec-
tion threshold for referral to central DXA of 15% FRAXMOF risk (current
national guideline in Sweden [31]) would, looking at the threshold
values, apply to approximately 40% of women in ages 65–69. To yield
a similar portion of womenwhen DXR-BMD is used for screening selec-
tion, a threshold of 0.490 g/cm² would be required. With those thresh-
olds, DXR-BMD captured 70% of all women in the population ages 65–
69 that had osteoporosis while a FRAX hip based strategy captured
62% and the FRAX MOF based strategy captured 57%. At the same time
the percentage of women who suffered incident fractures was similar
between each of the selected populations. However, Table 3 applies
for the unselected general population. In practice, there will always be
multiple pathways to an osteoporosis assessment (fracture liaison ser-
vices, indications related to speciﬁc drugs and diseases) that interact
with FRAX and DXR-BMD to different degrees. The population that
can be considered for screening is the survival population. Thus, if a sub-
stantial portion of the at-risk population is referred to osteoporosis as-
sessment through other pathways, care must be taken to properly
estimate the characteristics of the survival population. In addition to
Table 3 and Supplement Table 4, all source data in this study is available
for download through the SOF website [25].
Overall, the older age groups showed a similar pattern as ages 65–
69. The difference between the methods was further pronounced in
the 70–74 age group and smaller in the oldest age groups, 75–79 and
80+, where the prevalence of osteoporosis was higher.
The tableswere constructedwith 5-year-age spans to have sufﬁcient
number of fractures and cases. However, the fracture incidence rate is
higher at the high end of the age span than at the low end. Table 3 ap-
plies for the unselected general population and Supplement Table 4 ap-
plies for the subpopulation of only individuals with a prior fracture. The
former is intended for guidance in general age-based population screen-
ing and the later in screening of only peoplewith a prior fracture, and by
approximation, guidance in post-fracture workﬂows. Further guidance
and examples how Table 3 and Supplement Table 4 can be used are pre-
sented in the online supplement.
At a technical availability rate of DXR-BMD of 99.73%, the manage-
ment burden of individuals without a measurement should be minor
in relation the entire screening program. The false automatic validation
rate was 0.02%. Thus, relying on solely the automatic validation wouldnot have affected the fracture prediction performance or the osteoporo-
sis prediction performance of DXR-BMD.
This study has a number of strengths, including the size of the co-
hort, the comprehensive set of measurements and the duration and
completeness of follow-up. The study also has limitations, with a cohort
consisting of only Caucasian women over 65 and lacking data for men
and younger women. Another limitation is that besides rheumatoid ar-
thritis, there are 6 speciﬁc conditions associated with secondary osteo-
porosis that compose an additional component in FRAX. Data on these
6 conditions were not collected in SOF. However these conditions are
uncommon in healthy older women.
The recent expiration of patents for alendronic acid and zoledronic
acid has made case ﬁnding a larger part of the total cost of osteoporosis
management. Initiatives such as fracture liaison services and the UK
NOGG guidelines [32] have aimed to lower the cost of case ﬁnding in
order to increase the cared for population. Despite these efforts and
the reduced cost for treatment, the uptake of anti-osteoporotic treat-
ment has stagnated or even decreased in many countries [1].
In summary, DXR-BMD without additional clinical risk factors dis-
criminated fractures to a similar degree as FRAX and as lumbar spine
DXA BMD. DXR-BMD predicted femoral neck osteoporosis to a larger
degree than FRAX. The current analysis provides input data for cost
and performance comparisons between DXR-BMD and FRAX based sin-
gle tier and two-tier screening with conﬁrmation by central DXA, as
well as with single tier screening by central DXA. The data indicate
that in a healthcare setting where an individual is already at a digital
X-ray machine, such as at mammography screening or after a fracture,
automated DXR-BMD could be an efﬁcient and effective method to
ﬂag patients who might beneﬁt from an osteoporosis assessment. Re-
sults require conﬁrmation in other studies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bone.2016.02.011.
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Table 3
Ten year incidence of fracture by DXA FN BMD, FRAX (no BMD) and DXR-BMD and sensitivity to DXA FN T-score ≤−2.5 of FRAX (no BMD) and DXR-BMD.
Cumulative
percentage of
population
Threshold Major osteoporotic
fracture 10 year (%)
Hip fracture 10 year
(%)
Sensitivity to DXA FN
T-score ≤−2.5 (%)
DXA FN (g/cm²) FRAX hip (%) FRAX MOF (%) DXR (g/cm²) DXA FN FRAX DXR DXA FN FRAX DXR FRAX hip FRAX MOF DXR
65–69 years, N = 2343
0% – – – – – – – – – – – – –
10% 0.539 6.8 24.6 0.433 24.8 21.6 24.2 5.9 6.8 5.1 26 18 25
20% 0.582 4.5 19.3 0.456 21.8 19.7 21.6 4.9 5.6 3.4 39 38 43
30% 0.611 3.5 17.5 0.472 22.1 19.1 21.1 6.1 4.0 3.7 53 49 58
40% 0.639 2.9 15.4 0.488 20.0 18.1 19.6 5.2 4.1 3.5 62 57 70
50% 0.663 2.4 12.1 0.500 18.7 17.4 18.0 4.8 4.1 3.2 73 65 79
60% 0.689 2.0 10.8 0.515 17.1 16.2 16.1 4.1 4.0 3.1 83 80 85
70% 0.715 1.7 10.1 0.532 15.4 15.0 15.2 3.7 3.5 3.2 89 89 91
80% 0.753 1.4 9.4 0.551 14.7 14.1 14.4 3.4 3.4 3.2 94 94 97
90% 0.818 1.1 8.7 0.578 13.6 13.7 13.6 3.2 3.2 2.9 99 98 99
100% 1.270 0.4 5.0 0.678 12.9 12.9 12.9 2.9 2.9 2.9 100 100 100
70–74 years, N = 1674
0% – – – – – – – – – – – – –
10% 0.515 12.8 31.0 0.414 34.0 25.3 29.6 15.2 12.7 12.6 18 19 24
20% 0.551 9.0 24.3 0.437 29.2 24.4 27.8 12.7 12.0 10.5 34 31 40
30% 0.576 7.0 21.9 0.453 26.2 23.3 25.0 10.8 9.2 9.2 44 43 55
40% 0.606 5.9 19.6 0.467 25.4 21.6 22.5 10.5 9.2 8.2 56 55 69
50% 0.633 4.8 16.6 0.482 23.1 20.6 21.4 9.2 8.7 8.0 68 62 81
60% 0.657 4.0 14.1 0.496 21.7 20.3 20.1 8.3 7.7 7.4 77 73 87
70% 0.682 3.3 12.8 0.511 20.7 19.0 19.8 7.8 7.4 7.0 84 84 93
80% 0.718 2.8 11.9 0.529 19.7 18.2 19.0 7.3 7.1 6.8 92 93 96
90% 0.777 2.3 10.9 0.557 18.8 17.7 18.2 6.8 6.5 6.5 97 97 98
100% 1.084 0.8 6.3 0.669 17.2 17.2 17.2 6.2 6.2 6.2 100 100 100
75–79 years, N = 847
0% – – – – – – – – – – – – –
10% 0.500 21.9 38.2 0.395 40.2 31.7 37.2 21.4 16.7 15.5 15 15 19
20% 0.533 15.2 30.6 0.414 37.1 29.2 31.0 19.0 14.2 13.0 28 29 35
30% 0.558 11.7 27.9 0.433 34.2 30.5 29.5 18.2 14.2 13.0 43 44 49
40% 0.586 9.7 25.5 0.447 32.1 27.8 27.3 15.9 14.5 11.8 57 57 62
50% 0.606 8.2 22.2 0.458 31.7 28.3 25.9 16.5 13.7 11.6 67 64 69
60% 0.631 7.3 19.1 0.471 29.9 27.9 26.6 14.5 12.6 10.5 74 77 78
70% 0.659 6.2 17.2 0.484 28.2 26.5 27.0 13.5 12.2 10.5 84 84 86
80% 0.693 5.2 15.6 0.504 27.0 25.0 25.4 12.2 11.9 10.2 91 91 93
90% 0.743 4.2 14.0 0.539 25.1 24.0 24.7 10.9 10.8 10.4 95 95 98
100% 1.298 0.8 5.4 0.637 23.5 23.5 23.5 10.3 10.3 10.3 100 100 100
80+ years, N = 414
0% – – – – – – – – – – – – –
10% 0.472 27.6 45.7 0.377 61.5 31.6 39.5 41.5 22.0 24.4 12 13 16
20% 0.499 21.0 37.1 0.395 43.6 28.6 33.3 24.4 18.3 17.1 26 23 30
30% 0.529 16.7 33.9 0.409 41.4 28.0 36.1 25.2 17.1 18.5 37 38 43
40% 0.551 14.2 31.9 0.420 39.9 32.1 35.2 25.3 17.7 17.6 48 52 56
50% 0.577 12.2 29.3 0.432 38.6 34.2 36.0 23.8 19.4 18.4 59 61 67
60% 0.608 11.0 25.1 0.449 35.3 34.5 34.3 21.4 19.8 18.5 71 69 76
70% 0.633 9.7 22.3 0.461 33.5 35.7 33.1 19.4 19.0 18.0 85 81 84
80% 0.670 8.5 21.0 0.482 31.3 32.9 30.3 18.4 18.4 16.1 93 93 90
90% 0.721 7.4 19.4 0.507 29.6 30.3 29.7 16.7 16.7 15.9 98 98 95
100% 1.074 4.5 14.5 0.677 28.5 28.5 28.5 15.5 15.5 15.5 100 100 100
BMD: bone mineral density; DXA FN: femoral neck BMD by DXA; DXR: BMD by digital X-ray radiogrammetry; MOF: major osteoporotic fracture (clinical spine, hip, forearm or shoulder
fracture)
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